Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
A GCIG Intergroup Multi-Center Phase III Trial of Open-Label Carboplatin and Paclitaxel +/- NCI-Supplied Agent Bevacizumab (NSC #704865, IND #113912) Compared with Oxaliplatin and Capecitabine +/- Bevacizumab as First-Line Chemotherapy in Patients with Mucinous Epithelial Ovarian or Fallopian Tube Cancer (MEOC).
Closed to Accrual with Ongoing Follow-up
Anti-Angiogenesis, Chemotherapy: Systemic
Defintions of terms and FAQ about clinical trials.
Huyen Q. Pham, M.D.
Other Trial Staff:
Kristy Watkins, R.N., Grace Facio, R.N., Marissa Aldana, D.M., Yvonne Flores, D.M.
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.